SBC Medical Group
SBC
3 hedge funds and large institutions have $27.9K invested in SBC Medical Group in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
3.04% less ownership
Funds ownership: 3.06% → 0.02% (-3%)
40% less funds holding
Funds holding: 5 → 3 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
99% less capital invested
Capital invested by funds: $1.9M → $27.9K (-$1.87M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$22.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$244 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$1.12M |
| 2 |
Walleye Trading
New York
|
-$633K |
| 3 |
CS
Clear Street
New York
|
-$123K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $25.6K | +$22.9K | +1,970 | +159% |
|
|
TCM
2
Tuttle Capital Management
Riverside,
Connecticut
| $2.15K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $167 | +$244 | +21 | New |
|
|
4
Walleye Capital
New York
| – | -$1.12M | -86,054 | Closed |
|
|
5
Walleye Trading
New York
| – | -$633K | -48,407 | Closed |
|
|
CS
6
Clear Street
New York
| – | -$123K | -9,413 | Closed |
|
SBC Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q3 2024, worth a combined $27.9K — down 99% from $1.9M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SBC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $22.9K. The largest seller was Walleye Capital, exiting entirely with an estimated $1.12M sold.
- 3 institutional investors held SBC Medical Group (SBC) as of Q3 2024, down from 5 in Q2 2024.
- Funds reported $27.9K of SBC Medical Group stock for Q3 2024, down 99% quarter-over-quarter.
- 1 fund opened new SBC Medical Group positions in Q3 2024 and 3 closed out, a net change of -2 holders.
- The largest SBC Medical Group buyer in Q3 2024 was UBS Group, an estimated $22.9K added.
- The largest SBC Medical Group seller in Q3 2024 was Walleye Capital, an estimated $1.12M sold.
Based on aggregated 13F filings for Q3 2024.